Kellett Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Sell
340
-3
-0.9% -$3.06K 0.19% 59
2026
Q1
$315K Buy
343
+2
+0.6% +$2.03K 0.17% 60
2025
Q4
$366K Buy
341
+57
+20% +$54.5K 0.21% 54
2025
Q3
$217K Buy
284
+9
+3% +$6.7K 0.13% 71
2025
Q2
$214K Buy
275
+16
+6% +$12.4K 0.14% 66
2025
Q1
$214K Buy
+259
New +$216K 0.15% 68
2024
Q4
Sell
-287
Closed -$254K 75
2024
Q3
$254K Sell
287
-1,084
-79% -$975K 0.18% 61
2024
Q2
$1.24M Hold
1,371
1% 16
2024
Q1
$1.07M Hold
1,371
0.74% 23
2023
Q4
$799K Buy
1,371
+70
+5% +$40.9K 0.59% 29
2023
Q3
$699K Sell
1,301
-297
-19% -$153K 0.6% 23
2023
Q2
$749K Sell
1,598
-70
-4% -$29.4K 0.68% 20
2023
Q1
$573K Hold
1,668
0.55% 21
2022
Q4
$610K Hold
1,668
0.59% 21
2022
Q3
$604K Hold
1,668
0.74% 17
2022
Q2
$541K Buy
+1,668
New +$501K 0.7% 21

Other funds holding LLY

Kellett Wealth Advisors's LLY Position: Q2 2026 in Review

Kellett Wealth Advisors reduced its Eli Lilly (LLY) stake by 0.87% in Q2 2026, selling an estimated $3.06K and leaving 340 shares worth $408K. The position accounts for 0.19% of the portfolio, ranked #59.

Kellett Wealth Advisors first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.24M in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kellett Wealth Advisors held 340 shares of Eli Lilly worth $408K as of Q2 2026.
  • Kellett Wealth Advisors sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.19% of Kellett Wealth Advisors's portfolio in Q2 2026, its #59 holding.
  • Kellett Wealth Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • Kellett Wealth Advisors's Eli Lilly position peaked at $1.24M in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kellett Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.